Kelly, Deanna L <br/><br/>
Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).  [electronic resource] 

 -  BMC psychiatry  Aug 2013 
 - 214 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-244X 
<br/><br/><label>Standard No.: </label>10.1186/1471-244X-13-214  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antipsychotic Agents--adverse effects<br/>Aripiprazole<br/>Clinical Protocols<br/>Dopamine Agonists--therapeutic use<br/>Female<br/>Humans<br/>Hyperprolactinemia--blood<br/>Piperazines--therapeutic use<br/>Quinolones--therapeutic use<br/>Research Design<br/>Schizophrenia--complications